title: Rituximab treatment may disturb the normal pattern of lymphopoiesis after cord blood SCT.
authors.forename: P
authors.initials: P
authors.lastname: Barba
authors.forename: I
authors.initials: I
authors.lastname: Garcia-Cadenas
authors.forename: J
authors.initials: J
authors.lastname: Nomdedéu
authors.forename: R
authors.initials: R
authors.lastname: Martino
authors.forename: L
authors.initials: L
authors.lastname: Gallur
authors.forename: D
authors.initials: D
authors.lastname: Valcárcel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D005312:Fetal Blood / Q000166:cytology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D038041:Lymphopoiesis / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D000069283:Rituximab; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab